Immunology and Microbiology
T Cell
100%
Transplant Procedure
74%
Kidney Transplantation
67%
Dendritic Cell
37%
HLA Antibody
27%
Antibody Mediated Rejection
27%
Macrophage
24%
CD4
23%
Monospecific Antibody
23%
Intravenous Immunoglobulin
22%
Epitope
22%
Memory T Cell
21%
Mesenchymal Stem Cell
20%
T-Helper Cell
19%
Immunosuppressive Drug
18%
Continuous Ambulatory Peritoneal Dialysis
17%
Peritonitis
16%
Allotransplantation
16%
Liver Transplantation
15%
Adipose Tissue
15%
Interleukin 8
15%
Vaccination Policy
12%
T Cell Receptor
12%
Monocyte
11%
Peritoneal Dialysis
11%
Immune Complex
10%
Human Leukocyte Antigen
10%
CD8
10%
Mycophenolic Acid
8%
Tumor Necrosis Factor Alpha
8%
Alloreactive T Cell
7%
T Cell Proliferation
7%
Hemodialysis
7%
Cell Aging
7%
Tacrolimus
7%
Cell Level
7%
Cytomegalovirus
7%
Antigen Specificity
7%
Immune System
7%
Cytotoxic T-Cell
6%
Peritoneal Cavity
6%
CD68
6%
Transcriptome
6%
Interleukin-1
6%
Autoantibodies
5%
Solid Organ Transplantation
5%
Immunoassay
5%
Anti-Thymocyte Globulin
5%
Conjugate
5%
B Cell
5%
Medicine and Dentistry
Kidney Transplantation
66%
Kidney Graft
58%
T Cell
40%
Graft Survival
31%
Graft Failure
30%
Transplantation
29%
Nephropathy
26%
Immunosuppressive Drug
23%
Antibody Mediated Rejection
19%
Peritoneal Dialysis
17%
Peritoneal Fibrosis
16%
Continuous Ambulatory Peritoneal Dialysis
15%
Kidney Function
13%
Renal Failure
13%
Immunosuppressive Treatment
13%
Diseases
13%
Mycophenolic Acid
13%
Antibodies
12%
Infection
12%
HLA Antibody
11%
Acute Kidney Injury
11%
Mesothelial Cell
11%
Peritonitis
11%
Tumor Antigen
10%
Hyponatremia
10%
HIV-associated Nephropathy
10%
Liver Transplantation
10%
Nephrectomy
10%
Dendritic Cell
10%
Tacrolimus
10%
Drug Therapy
9%
Liver Graft
9%
Hazard Ratio
9%
Monotherapy
8%
Randomized Controlled Trial
8%
Dialysis Fluid
7%
Cerebral Salt Wasting
7%
Rituximab
7%
T-Helper Cell
7%
Highly Active Antiretroviral Therapy
6%
HLA Matching
6%
Hemodialysis
6%
Renal Biopsy
6%
Contraindication
6%
Acute Brain Disease
6%
Peritoneal Cavity
6%
Quality of Life
6%
Epitope
6%
Thymocyte Antibody
5%
Desensitization
5%
Pharmacology, Toxicology and Pharmaceutical Science
Immunosuppressive Agent
30%
Peritonitis
20%
Tacrolimus
20%
Mycophenolic Acid
19%
Peritoneal Fibrosis
15%
Cerebral Salt Wasting
15%
Hyponatremia
15%
End Stage Renal Disease
10%
Acute Kidney Failure
10%
Randomized Controlled Trial
8%
Monotherapy
8%
Infection
7%
Acute Brain Disease
6%
Calcineurin Inhibitor
6%
Dialysis Fluid
6%
Disease
5%
Proteinuria
5%
Hemodialysis
5%
Staphylococcus Aureus
5%
Tumor Antigen
5%
Alpha Tocopherol
5%
Rhabdomyolysis
5%
Urinary Tract Disease
5%
Myoglobinuria
5%
Hemoglobinuria
5%
Myopathy
5%
Frailty
5%
Liver Fibrosis
5%
Enzyme-Linked Immunosorbent Assay
5%
Vaccination Policy
5%
Cytomegalovirus Infection
5%
Obesity
5%
Random Effects Model
5%
Hematuria
5%
Replacement Therapy
5%
Kidney Disease
5%
Creatinine
5%
Pharmacokinetics
5%
Open-Label Trial
5%
Hypotension
5%
Hetastarch
5%
Everolimus
5%
Gastrointestinal Symptom
5%
Salt Wasting
5%
Alemtuzumab
5%
Symptom
5%
